GPX4-deficient T cells can rapidly accumulate membrane LPO and lead to ferroptosis, and therapeutic induction of ferroptosis in tumor cells by GPX4 inhibitors may have unnecessary effects on T cells. This evidence concerns the gene GPX4 and neoplasm.